ConductScience.org, home

Paper3971375

A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice.

Sekine K and 5 others. Cancer Res, 1985. Cited by 105 papers, by iCite.

Cite this record

ConductScience Library. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Papers, record 3971375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3971375

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice.
PubMed
Journal
Cancer Res
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
105
iCite
Relative citation ratio, by iCite
3.37
iCite
Revised in PubMed
2014-11-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sekine KK
2Toida TT
3Saito MM
4Kuboyama MM
5Kawashima TT
6Hashimoto YY

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
BifidobacteriumMajor topic
Neoplasms, ExperimentalMajor topic
PeptidoglycanMajor topic
Animals
Cell Wall
In Vitro Techniques
Male
Mice
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04046432Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora, Peristalsis, Immunity, and Anti-oxidative CapacityResultsClinicalTrials.gov
NCT04088474Effects of Vigiis 101-LAB on a Healthy Populations' Gut MicrofloraResultsClinicalTrials.gov

Download CSV of trials

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMIDTitleJournalYearIn PapersSource
41917413The Sizes and Shapes of Glycan-Presenting Particles Determine IL-12 Production from Mononuclear Phagocytes via a Glycan-Dependent Phagocytic Process.Adv Exp Med Biol2026https://conductscience.org/library/papers/41917413PubMed
40607403Peptidoglycan derived from Lacticaseibacillus rhamnosus and Lactobacillus acidophilus suppress TLR2/1-mediated inflammation in bovine endometrial epithelial cells.Front Immunol2025https://conductscience.org/library/papers/40607403PubMed
39796098Structural Characterization and Immune Activation Capacity of Peptidoglycan from Corynebacterium glutamicum in RAW264.7 Cells.Int J Mol Sci2024https://conductscience.org/library/papers/39796098PubMed
39481288Development and mechanism exploration of a quantitative model for Escherichia coli transformation efficiency based on ultrasonic power.Ultrason Sonochem2024https://conductscience.org/library/papers/39481288PubMed
39339770Yoyo Dieting, Post-Obesity Weight Loss, and Their Relationship with Gut Health.Nutrients2024https://conductscience.org/library/papers/39339770PubMed
39338524Identification of Bioactive Substances Derived from the Probiotic-Induced Bioconversion of Lagerstroemia speciosa Pers. Leaf Extract That Have Beneficial Effects on Diabetes and Obesity.Microorganisms2024https://conductscience.org/library/papers/39338524PubMed
38375206Loss of symbiotic and increase of virulent bacteria through microbial networks in Lynch syndrome colon carcinogenesis.Front Oncol2023https://conductscience.org/library/papers/38375206PubMed
36144335Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?Microorganisms2022https://conductscience.org/library/papers/36144335PubMed
36101996The effect of <em>Lactobacillus casei</em> and <em>Bacillus coagulans</em> probiotics on liver damage induced by silver nanoparticles and expression of Bax, Bcl2 and Caspase 3 genes in male rats.Eur J Transl Myol2022https://conductscience.org/library/papers/36101996PubMed
36016797Wall teichoic acid-dependent phagocytosis of intact cell walls of Lactiplantibacillus plantarum elicits IL-12 secretion from macrophages.Front Microbiol2022https://conductscience.org/library/papers/36016797PubMed
35603970Probiotic Engineering and Targeted Sonoimmuno-Therapy Augmented by STING Agonist.Adv Sci (Weinh)2022https://conductscience.org/library/papers/35603970PubMed
34721321Anti-cancer Substances and Safety of Lactic Acid Bacteria in Clinical Treatment.Front Microbiol2021https://conductscience.org/library/papers/34721321PubMed
34030655The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal.BMC Microbiol2021https://conductscience.org/library/papers/34030655PubMed
33603997Anti-proliferative effects of cell wall, cytoplasmic extract of Lactococcus lactis and nisin through down-regulation of cyclin D1 on SW480 colorectal cancer cell line.Iran J Microbiol2020https://conductscience.org/library/papers/33603997PubMed
32995642Effects of Vigiis 101-LAB on a healthy population's gut microflora, peristalsis, immunity, and anti-oxidative capacity: A randomized, double-blind, placebo-controlled clinical study.Heliyon2020https://conductscience.org/library/papers/32995642PubMed
32819443Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods.Microb Cell Fact2020https://conductscience.org/library/papers/32819443PubMed
31648597Double deletion of murA and murB induced temperature sensitivity in Corynebacterium glutamicum.Bioengineered2019https://conductscience.org/library/papers/31648597PubMed
31213556Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways.mBio2019https://conductscience.org/library/papers/31213556PubMed
30410487Vaginal Lactobacilli Induce Differentiation of Monocytic Precursors Toward Langerhans-like Cells: in Vitro Evidence.Front Immunol2018https://conductscience.org/library/papers/30410487PubMed
29963126Antitumor mechanisms of bifidobacteria.Oncol Lett2018https://conductscience.org/library/papers/29963126PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3971375

GET https://conductscience.org/api/papers/v1/3971375/cited_by?page=2